Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study (Q80633269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Knight K

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Wang L

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Clark RE

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

19 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

2287-2295

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637811%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404858

2 January 2020

exact match

0 references

cites work

BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

The optimization of helper T lymphocyte (HTL) function in vaccine development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Molecular status of individual CFU-GM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Dynamics of chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404858

7 January 2021